Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia

E-ISSN： 1875-5305|22|6|539-546

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.22, Iss.6, 2015-06, pp. : 539-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine-dependent B cell–T cell interactions in chronic lymphocytic leukemia and multiple myeloma – targets for therapeutic intervention?

By Jöhrer Karin Hofbauer Sebastian W Zelle-Rieser Claudia Greil Richard Hartmann Tanja N

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 425-441

Informa Healthcare

Access to resources Recommend Favorite

Rituximab for chronic lymphocytic leukemia

By Robak Tadeusz

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 503-515

Informa Healthcare

Access to resources Recommend Favorite

Anti-CD37 antibodies for chronic lymphocytic leukemia

By Robak Tadeusz Robak Pawel

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 651-661

Informa Healthcare

Access to resources Recommend Favorite

Tumour Targeting with Rationally Modified Cell-Penetrating Peptides

By Mäe Maarja

International Journal of Peptide Research and Therapeutics, Vol. 18, Iss. 4, 2012-12 ,pp. : 361-371

Springer Publishing Company

Access to resources Recommend Favorite

Human Protein 53-Derived Cell-Penetrating Peptides

By Suhorutsenko Julia

International Journal of Peptide Research and Therapeutics, Vol. 18, Iss. 4, 2012-12 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite